John Idoine, DO
Orthopaedic Surgery · Dover, OHNPI 1437324605
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.2%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Stryker at 57.8% of the total. Reporting peaked in 2019 at $4,840 and has fallen 82.6% since, to $842 in 2025.
Across 82 payments — averaging $142.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$7K
- Arthrex$3K
- Rock Medical Orthopedics, Inc.$2K
- Zimmer Biomet$334
- DJO, LLC$107
- Johnson & Johnson$32
- plus $50 from 2 others
What the payments were for
- Speaking & faculty fees$751%
- Travel & lodging$5,16244%
- Food & beverage$3,85633%
- Education$1,20010%
- Gifts$1,38812%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 46 | $6,757 |
| Arthrex | 19 | $2,687 |
| Rock Medical Orthopedics, Inc. | 9 | $1,714 |
| Zimmer Biomet | 3 | $334 |
| DJO, LLC | 1 | $107 |
| Johnson & Johnson(2 entities) | 2 | $32 |
| Dynasplint Systems Inc. | 1 | $25 |
| Smith+Nephew | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BLUEPRINT PSI SYSTEM$1,834
- MAKO$1,586
- Ascend Flex$1,388
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$494
- AIRCAST$214
- PROFYLE$174
- PERFORM GLENOID$154
- ROSA$134
- T2 ALPHA$128
- PANGEA$128
- AEQUALIS PERFORM REVERSED$128
- Persona$116
- AEQUALIS$109
- AEQUALIS FLEX REVIVE$107
- DONJOY$107
How this compares
$11,680 in reported general payments places this provider in the 75th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 30 | $1,471 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 72 | $577 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 64 | $440 |
| Doxycycline Monohydrate | 31 | $324 |
| Methylprednisolone | 59 | $269 |
| Ondansetron Hcl | 44 | $236 |
| Diclofenac Sodium | 19 | $172 |
| Doxycycline Hyclate | 16 | $135 |
| Tramadol Hcl | 28 | $92 |
| Cephalexin | 24 | $32 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Dover
- Reuben GobezieCleveland$12M
- Gregory BerletWorthington$9.6M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.8M
- Joseph IannottiCleveland$7.1M
- John SontichYoungstown$3.6M
- Anthony MiniaciCleveland$3.1M
- David WelkerMiamisburg$2.8M
- Kenneth GreeneCleveland$2.6M
- Mark FroimsonCleveland$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.